Clinical Trials in Arizona

Showing 11181-11200 of 14,395 trials

Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461

NCT02329184

The purpose of this study is to establish initial safety, tolerability, pharmacokinetics and pharmacodynamics of MYK-461 in human subjects. This is a sequential group, single ascending (oral) dose study in NYHA Class I, II, or III patient volunteers aged 18-65 years.

Hypertrophic Cardiomyopathy

MyoKardia, Inc.15 participantsStarted Dec 2014

Scottsdale, Arizona, United States • Cypress, California, United States • Stanford, California, United States +4 more locations

COMPLETEDPhase 131 miles

A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers

NCT01209195

This study was a Phase 1 and pharmacologic open-labeled dose-escalation trial of MM-121 in combination with paclitaxel using a "3+3" design.

Locally Advanced/Metastatic or Recurrent Ovarian Cancer, Fallopian Tube Cancer,Primary Peritoneal Cancer or Endometrial CancerLocally Advanced/Metastatic Her2 Non Overexpressing Breast Cancer

Merrimack Pharmaceuticals41 participantsStarted Oct 2010

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Bakersfield, California, United States +2 more locations

COMPLETED31 miles

Robotic-assisted Versus Laparoscopic Sigmoid Resection

NCT02636673

Retrospective multi-center comparative chart review of robotic-assisted versus laparoscopic sigmoid resection for both benign and malignant disease

Sigmoid Diseases

Intuitive Surgical518 participantsStarted Nov 2015

Scottsdale, Arizona, United States • Miami, Florida, United States • Tampa, Florida, United States +3 more locations

Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461

A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers

Robotic-assisted Versus Laparoscopic Sigmoid Resection

Find Trials by Condition in Arizona

A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine

Drug Interaction Study of MGL-3196 With Atorvastatin

Bipolar Study in Adults at Least 18 Years of Age

Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients

Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa

Study Evaluating the Safety of Intranasal Administration of 400 μg of Fluticasone Propionate Twice a Day (BID) Using a Novel Bi-Directional Device in Subjects With Chronic Sinusitis With or Without Nasal Polyps

Safety and Efficacy of Mipomersen (ISIS 301012) As Add-on Therapy in High Risk Hypercholesterolemic Patients

Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration

Efficacy and Safety Study of ISIS 301012 (Mipomersen) as Add-on in Familial Hypercholesterolemic Patients With Coronary Artery Disease

Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex

Study of the Safety and Local Tolerability of Intranasal Gel Formulations of XF-73

A Study of Vemurafenib (RO5185426) in Participants With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation

HeartLight Ablation in Patients With Paroxysmal Atrial Fibrillation (PAF)

Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism

Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-Experienced Genotype 1 Hepatitis C Infected Patients (STARTverso 3)

Hormone Responses During Hypoglycemia and the Accuracy of Continuous Glucose Monitors